TNF and inflammatory bowel disease: Current therapy for the IBD patients included anti‐TNFα therapy (alone or in association with other drugs, n=29), salicylates (alone or in association with other drugs except for anti‐TNFα therapy, n=107), and other disease‐modifying drugs (without anti‐TNFα therapy and salicylates, n=31).